Clinical Trial Update: Efficacy and Safety of Monoclonal Antibody in Acute Phase of Neuromyelitis Optica Spectrum Disorder

View source ↗

Summary

A clinical trial update reports on the efficacy and safety of a monoclonal antibody in the acute phase of Neuromyelitis Optica Spectrum Disorder; the study is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuromyelitis Optica Spectrum Disorder

Drugs mentioned

• Unnamed monoclonal antibody (NCT07182409)

Snippet

Sponsor: First Affiliated Hospital of Chongqing Medical University | Conditions: NMOSD | Status: NOT_YET_RECRUITING